Safety, tolerability, pharmacokinetics, and neutralisation activities of the anti-HIV-1 monoclonal antibody PGT121.414.LS administered alone and in combination with VRC07-523LS in adults without HIV in the USA (HVTN 136/HPTN 092): a first-in-human, open-label, randomised controlled phase 1 trial

Kupferwasser DK, Kang AY, Bolaris M, Huse H, Chen L, Miller L. Diagnostic stewardship cutoffs for urinalysis results prior to performing a urine culture: analysis[...]

Ali A, Balamurugan A, Ibarrondo FJ, Nguyen M, Habibipour S, Lim JM, Hofmann C, Ng HL, Yang OO. Bispecific antibodies cross-link and redirect CD8+ T cells[...]

Zaman F, Zhu X, Hunt JH, Rozek G, Eby Y, Hussain S, Desai NM, Florman S, Rana MM, Friedman-Moraco R, Pereira MR, Mehta S, Stock[...]